---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-064144"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2025-06-30T23:59:59+00:00"
generated_at: "2026-05-18T13:04:58.711394+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nasdaq grants Entero Therapeutics extension to Oct 8, 2025 to meet minimum equity requirement

## Summary
- Company received Nasdaq extension letter on June 25, 2025; deadline to regain compliance is October 8, 2025.
- Must meet Nasdaq Rule 5550(b)(1) minimum stockholders' equity of $2.5 million.
- As of Dec 31, 2024, stockholders' equity was negative $3.88 million, triggering the deficiency.
- Failure to regain compliance may result in delisting, but appeal to a Nasdaq Hearing Panel is permitted.
- No assurance that compliance will be achieved or listing maintained.

## SEC filing metadata
- accession: 0001104659-25-064144
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2025-06-30T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465925064144/0001104659-25-064144-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465925064144/tm2519504d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-064144
- JSON: https://secwatch.observer/filing/0001104659-25-064144.json
- Plain text: https://secwatch.observer/filing/0001104659-25-064144.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.